[144] Magnite, Inc. SEC Filing
Insider sale notice for Magnite, Inc. (MGNI): This Form 144 reports a proposed sale of 20,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $492,148.00, with an approximate sale date of 09/09/2025 on NASDAQ. The filing lists recent acquisitions of the shares: purchases via the Employee Stock Purchase Plan on 05/15/2025 and prior ESPP and restricted stock vesting dates between 2023 and 2025. The filer also disclosed sales earlier in September and August 2025 totaling 40,201 shares with gross proceeds shown. The notice includes the signer’s representation of no undisclosed material adverse information.
- Compliance disclosure filed under Rule 144, providing transparency on insider sales and acquisitions
- Shares acquired via ESPP and registered plan vesting, indicating standard employee compensation sources
- Insider plans to sell 20,000 shares (aggregate market value $492,148), which may be viewed by some investors as insider liquidity
- Recent prior sales in Aug–Sep 2025 total 40,201 shares with stated gross proceeds, showing significant insider sell activity
Insights
TL;DR: Routine Rule 144 notice showing an insider’s planned sale and recent transactions; disclosure is compliance-focused, not a company performance statement.
The filing documents a proposed sale of 20,000 shares valued at $492,148 and lists recent acquisitions (ESPP purchases and restricted stock vesting) from 2023–2025, indicating these shares were acquired under standard employee programs. It also records prior sales of 20,000, 9,315, and 10,886 shares in Aug–Sep 2025 with stated gross proceeds. For investors, this is primarily a transparency and insider-liquidity signal rather than a direct measure of corporate operational performance; no earnings, guidance, or corporate actions are disclosed here.
TL;DR: The filing reflects compliance with SEC resale rules and contains standard representations about material nonpublic information.
The Form 144 shows the seller relied on shares acquired through an ESPP and restricted stock vesting under registered plans, and it includes the required attestation about lacking undisclosed material adverse information. The presence of multiple recent sales and the planned sale should be interpreted as insider liquidity activity; the filing itself does not provide evidence of governance issues or regulatory concerns.